Core Viewpoint - The strategic partnership between Meili Tianyuan Medical Health and Shiseido China aims to enhance the high-end brand ecosystem and improve service customization in the beauty and skincare market [1][3]. Company Overview - Meili Tianyuan operates over 734 stores across 20 first-tier and new first-tier cities in China, serving more than one million customers annually, primarily high-income women [3]. - The company has experienced significant growth, with a projected revenue of at least 3 billion yuan for 2025, representing a year-on-year increase of no less than 16% [4]. Strategic Partnership - Meili Tianyuan will serve as the exclusive launch platform for Shiseido's RQ PYOLOGY brand in high-end beauty salons, integrating RQ PYOLOGY's products and services into its store network [1][3]. - The collaboration aims to connect medical beauty recovery with daily skincare, aligning with Meili Tianyuan's "dual beauty" strategy of integrating lifestyle and medical beauty [3][4]. Financial Performance - The company anticipates adjusted net profits of at least 380 million yuan for 2025, reflecting a year-on-year growth of no less than 40% [4]. - The acquisition of the second-largest beauty chain, Nairui, has contributed to a significant increase in net profit margins, from 6.5% pre-acquisition to 10.4% in the first half of 2025 [5]. Industry Context - The domestic high-end beauty and medical beauty market is undergoing structural adjustments, with a shift towards systematic and scientific skincare services [6]. - The partnership reflects a shared understanding of the trend towards enhanced service experiences and professional endorsements in the high-end female consumer market [6].
美丽田园牵手资生堂中国